Need Help?

Transcriptome Sequencing Data of High Grade Serous Ovarian Cancer

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001006456 unspecified 212
Publications Citations
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Sci Rep 11: 2021 8856
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.
Nat Commun 12: 2021 3904
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Sci Adv 8: 2022 eabm1831
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.
Front Oncol 12: 2022 954430
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Dev Cell 58: 2023 1106-1121.e7
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.
BMC Cancer 24: 2024 173
Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level.
Sci Rep 14: 2024 4322